Cite
HARVARD Citation
Brunner, H. et al. (2023). Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. Annals of the rheumatic diseases. 82 (1), pp. 154-160. [Online].